Jiangsu Hengrui Pharmaceuticals Co., Ltd. (JNGHF)
OTC
Closed
Oct 6, 2026
Day's Range
5.8052 wk Range
5.80Overview - JNGHF - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Key Statistics
Valuation
Enterprise Value
-40.88B
P/E (Trailing)
‪34.11‬
Price / Book
‪4.15‬
EV / EBITDA
‪-4.30‬
Profitability
Gross Margin
‪86.02%‬
Profit Margin
‪86.20%‬
Operating Margin
‪27.57%‬
Return on Assets
‪11.03%‬
Return on Equity
‪12.47%‬
Ownership
Shares Outstanding
6.63B
Held by Insiders
‪0.00%‬
Held by Institutions
‪77.32%‬
Price stats
50-Day Avg
‪5.96‬
200-Day Avg
‪5.96‬
Dividends
Payout Ratio
‪0.00%‬
Peers - JNGHF - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
- JNGHFOTCJiangsu Hengrui Pharmaceuticals Co., Ltd.-52.93%52-week change34.12P/E (Trailing)‪86.20%‬Profit Margin
- MYCOFOTCNoveris Health Sciences Inc.+81.51%52-week change0.43P/E (Trailing)‪0.00%‬Profit Margin
- HDRPFOTCEpsilon Healthcare Limited+86.00%52-week change-2.94P/E (Trailing)‪0.47%‬Profit Margin
- NUGSOTCCannabis Strategic Ventures Inc.+98.63%52-week change-0.18P/E (Trailing)‪-38.63%‬Profit Margin
- PAIOFOTCPaion AG+85.71%52-week change-0.88P/E (Trailing)‪-134.11%‬Profit Margin
- BWVIOTCPsycheceutical Bioscience, Inc.+75.00%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- QMDTOTCQuick-Med Technologies Inc.+80.00%52-week change—P/E (Trailing)‪-76.79%‬Profit Margin
Profile Summary - JNGHF - Jiangsu Hengrui Pharmaceuticals Co., Ltd.
About
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, autoimmune conditions, pain management, anti-infectives, and other…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
